Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University College Cork
Rutgers, The State University of New Jersey
University Hospital Tuebingen
Dana-Farber Cancer Institute
National Institutes of Health Clinical Center (CC)
University Health Network, Toronto
Mayo Clinic
The Netherlands Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
Washington University School of Medicine
Fudan University
Jonsson Comprehensive Cancer Center
Hospital Israelita Albert Einstein
West China Hospital
UNICANCER
MedSIR
Instituto do Cancer do Estado de SĂŁo Paulo
German Cancer Research Center
Sun Yat-sen University
Institute of Cancer Research, United Kingdom
UNICANCER
Fudan University
Shanghai Bovax Biotechnology Co., Ltd.
The Netherlands Cancer Institute
University of Maryland, College Park
The Affiliated Hospital of Qingdao University
SCG Cell Therapy Pte. Ltd.
University Medical Center Groningen
Shanghai Bovax Biotechnology Co., Ltd.
University of Maryland, College Park
Latin American Cooperative Oncology Group
UNICANCER
HRYZ Biotech Co.
Deciphera Pharmaceuticals, LLC
Dana-Farber Cancer Institute
The Affiliated Hospital of Qingdao University
A.O.U. CittĂ della Salute e della Scienza
Centre Hospitalier Universitaire de Besancon
National Institutes of Health Clinical Center (CC)
The Christie NHS Foundation Trust
Xencor, Inc.
University Hospitals Bristol and Weston NHS Foundation Trust
University of Alabama at Birmingham
Sun Yat-sen University
Memorial Sloan Kettering Cancer Center
Institut de Cancérologie de Lorraine
Karolinska Institutet